Figure 1.
Cumulative incidence of grade 3–4 AEs and of drug discontinuation accounting for competing events (death and progressive disease). (A) Cumulative incidence of grade 3–4 non-hematologic toxicities. (B) Cumulative incidence of grade 3–4 infections, cardiac or gastrointestinal toxicities. (C) Cumulative incidence of drug discontinuation.